Estudios originales

Published on 12 de junio de 2018 | http://doi.org/10.5867/medwave.2018.03.7211

Observational study to analyze patterns of treatment of breakthrough dyspnea in cancer patients in clinical practice

Back to article Table 3.

Drug substances and interventions prescribed as first-choice therapy for the management of breakthrough dyspnea.